Does SECUKINUMAB Cause Therapeutic product effect delayed? 162 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 162 reports of Therapeutic product effect delayed have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.1% of all adverse event reports for SECUKINUMAB.
162
Reports of Therapeutic product effect delayed with SECUKINUMAB
0.1%
of all SECUKINUMAB reports
0
Deaths
14
Hospitalizations
How Dangerous Is Therapeutic product effect delayed From SECUKINUMAB?
Of the 162 reports, 14 (8.6%) required hospitalization, and 8 (4.9%) were considered life-threatening.
Is Therapeutic product effect delayed Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 162 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Therapeutic product effect delayed?
ADALIMUMAB (244)
TOFACITINIB (178)
CARBIDOPA\LEVODOPA (168)
POLYETHYLENE GLYCOL 3350 (125)
RIMEGEPANT (120)
TASIMELTEON (93)
DUPILUMAB (90)
IBUPROFEN (88)
DICLOFENAC (85)
ERENUMAB-AOOE (82)
Which SECUKINUMAB Alternatives Have Lower Therapeutic product effect delayed Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG